Response Genetics Closes UK Facility in Consolidation | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Response Genetics said today that it is closing its UK-based facility in a cost-cutting move expected to save $2.3 million annually.

The company disclosed in a filing with the US Securities and Exchange Commission that it has laid off all of its UK employees, a total of nine positions, including James Clark, its UK-based COO.

The reduction in force will be "substantially complete" on March 31, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.